Ozempic: DH recommends alternative diabetes drugs as shortages persist

The DH has said that patients with type two diabetes can be initiated on or switched to alternative treatments amid ongoing shortages of semaglutide and other GLP-1 RAs.

Semaglutide injection
Victoza (liraglutide) is out of stock until the end of 2024

Patients with type two diabetes can be initiated on Mounjaro Kwikpens (tirzepatide) or Rybelsus tablets (semaglutide), according to a Department of Health and Social Care (DH) medicine supply notification announced by Community Pharmacy England (CPE) this week (March 18).

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

James Stent

Read more by James Stent

James Stent joined C+D as a digital reporter in May 2023 from the South African human rights news agency GroundUp, where he was senior reporter and consultant editor.

Latest from News

Retired pharmacist crushed to death in canal boat accident

 
• By 
 • comment0

Margaret Billings sustained fatal injuries when she was caught between a moving boat and a riverbank during a day out “with family and friends”, an inquest has found.

NHSE scrapped: ‘Fresh start or just more political chaos?’

 
• By 
 • comment4

C+D rounds up some of the immediate pharmacy reaction to news that NHS England will be abolished, with more control moving back to the government and local leaders…

New primary care medical director role as 2-year NHSE axing begins

 
• By 
 • comment3

Wes Streeting has revealed that the DH is “immediately” working to scrap NHS England (NHSE) and put a new “transformation team” in place – adding that it is in the “very final stages” of concluding a new pharmacy contract deal.

More from Clinical

exclusive

Paydens reveals rollout of ‘same-day’ private prescribing service

 
• By 
 • comment

Paydens Pharmacy has announced the rollout of a private prescribing service that allows patients to access same-day care “without needing to see their GP” for £15 per consultation.

Boots to ‘review processes’ after caught dispensing Wegovy to teen

 
• By 
 • comment

The health secretary has deemed Boots weight loss safeguards “totally unacceptable” after a new Dispatches documentary found that the pharmacy provided a 16-year-old with Wegovy against its own policy.